Cafepharma Today

March 27 2025 - RFK Jr. prepares 10,000 more job cuts across HHS, outlines office consolidations
RFK Jr. prepares 10,000 more job cuts across HHS, outlines office consolidations
GLP-1s outpace specialty drug spend for the first time
FDA staff struggle to meet product review deadlines after DOGE layoffs
FDA fast-tracks Sanofi's experimental chlamydia vaccine
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MacroGenics axes ADC drug following Phase II failure in prostate cancer
Clinical Trials Arena
Tuesday, March 25, 2025 - 10:27am
tags:
Macrogenics, clinical trials, prostate cancer, vobra duo
AbbVie takes Genmab to court, accusing partner of being 'willfully blind' to ADC trade secret theft
Fierce Biotech
Tuesday, March 25, 2025 - 10:25am
tags:
AbbVie, Genmab, legal, trade secrets
The industry heavyweight behind Novavax’s push to bounce back
Pharma Voice
Tuesday, March 25, 2025 - 10:24am
tags:
Novavax, vaccines, R&D
European countries, universities implement initiatives to attract US researchers amid 'brutal funding cuts'
Fierce Biotech
Tuesday, March 25, 2025 - 10:23am
tags:
Europe, The Netherlands, R&D, funding, federal funding, Donald Trump
Verve gets FDA green light to expand base editing trial into US
BioPharma Dive
Tuesday, March 25, 2025 - 10:22am
tags:
Verve Therapeutics, gene editing, clinical trials, VERVE-102, cholesterol
FDA starts review of Sanofi's MS hope tolebrutinib
Pharmaphorum
Tuesday, March 25, 2025 - 10:20am
tags:
Sanofi, FDA, tolebrutinib, MS, multiple sclerosis
Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks
Fierce Biotech
Monday, March 24, 2025 - 11:20am
tags:
Novo Nordisk, obesity, United Laboratories, triple G agonists, UBT251
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
CNBC
Monday, March 24, 2025 - 11:18am
tags:
23andMe, bankruptcy, Anne Wojcicki, Medtech, diagnostics
Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset
Fierce Biotech
Monday, March 24, 2025 - 11:08am
tags:
Mira Pharmaceuticals, M&A, Skny Pharmaceuticals, obesity, smoking cessation
Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge
Fierce Pharma
Monday, March 24, 2025 - 11:07am
tags:
Biogen, headquarters, Cambridge, Massachusetts
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy
Fierce Pharma
Monday, March 24, 2025 - 11:05am
tags:
Novo Nordisk, Wegovy, NovoCare Pharmacy, obesity
Elypta’s urine test identifies 90% of recurrent kidney cancer cases
Clinical Trials Arena
Monday, March 24, 2025 - 11:03am
tags:
Elypta, diagnostics, kidney cancer
Brazil's Hypera to launch an Ozempic generic in 2026, CEO says
MSN/Reuters
Monday, March 24, 2025 - 11:02am
tags:
Hypera Pharma, semaglutide, generics, Ozempic, Novo Nordisk
Pharmaceutical supply chain headed for $5.3B valuation
Yahoo Finance
Monday, March 24, 2025 - 11:00am
tags:
pharma industry, supply chain
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Monday, March 24, 2025 - 10:58am
tags:
Eli Lilly, Novo Nordisk, obesity, DTC, Mounjaro, Wegovy
Phase 3 readout puts Opthea at risk of insolvency
Pharmaphorum
Monday, March 24, 2025 - 10:57am
tags:
Opthea, clinical trials, wet age-related macular degeneration, sozinibercept
MIT team develops 'years-long' drug delivery tech
Pharmaphorum
Monday, March 24, 2025 - 10:56am
tags:
MIT, drug delivery
Chimerix engaged with 7 other biopharmas before choosing Jazz’s $935M deal—here’s why it won
Fierce Biotech
Sunday, March 23, 2025 - 11:45pm
tags:
Jazz Pharma, Chimerix, M&A
FDA rejects Hengrui, Elevar's PD-1 cancer drug combination—again
Fierce Pharma
Sunday, March 23, 2025 - 11:43pm
tags:
Jiangsu Hengrui, Elevar Therapeutics, camrelizumab, FDA, cancer
Trump Allies Aim to Slash Drug Prices. The Pharma Industry Is in a Bind.
Barron's
Sunday, March 23, 2025 - 11:41pm
tags:
Donald Trump, drug pricing

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Alkanes on Mars
In the Pipeline
Starving Cancer Cells Where They Live
In the Pipeline
Informa Connect’s Life Sciences Pricing & Contracting USA
Drug Channels
Evolving the Ability to Evolve
In the Pipeline
Metamorphine, An Unwelcome Product
In the Pipeline
The End of the Blockbuster Era: Unlocking Growth with Direct-to-Patient Commercialization
Drug Channels
A New Type of Antifungal
In the Pipeline
The Continuing Crisis, Part IX: Inside the NIH Now
In the Pipeline
NOW AVAILABLE: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.